ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7
Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds
Targeting One Specific Protein Can Double PFS; Triple Overall Survival
Revlimid Maintenance Therapy Delayed Progression by 90%
Drug Effectiveness Weakens After Three Years, Study Says
Nexavar Improves PFS In HER-2 Negative Breast Cancer
Xgeva Significantly Increases Bone Metastasis-Free Survival
U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians
Urocidin May Provide Alternative To Cystectomy in BCG Cancers
Clinical Trials Approved By NCI CTEP Last Month
Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors
Abbott PCR Test For HCV Load Sensitive to Within 12 IU/mL
Trending Stories
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Twitter star Vinay Prasad retires @VinayPrasadMD
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Should I have a drink tonight?
In anticipation of the first holiday season since the surgeon general’s report on alcohol and cancer, we ask experts to weigh in - 2025 in review: In a mess, there is movement—and leadership does matter
- The Cancer Letter’s most-read stories of 2025
As MAHA-led policies took hold, oncology navigated through uncertainty and turmoil
